Recent LGVN News
- Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs) • GlobeNewswire Inc. • 04/08/2026 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:00:38 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/25/2026 02:13:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:01:06 PM
- The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed • GlobeNewswire Inc. • 03/18/2026 03:30:00 PM
- A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. • PR Newswire (Canada) • 03/18/2026 02:00:00 PM
- A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. • PR Newswire (US) • 03/18/2026 02:00:00 PM
- Longeveron Announces 2025 Full Year Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/17/2026 08:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 08:01:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:05:29 PM
- Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026 • GlobeNewswire Inc. • 03/12/2026 01:00:00 PM
- Longeveron Announces Closing of Private Placement of up to $30 Million • GlobeNewswire Inc. • 03/11/2026 08:05:00 PM
- Longeveron Secures $15M Financing With Potential for Additional $15M Tied to Trial Milestones • IH Market News • 03/10/2026 02:33:43 PM
- Longeveron Announces Private Placement of up to $30 Million • GlobeNewswire Inc. • 03/10/2026 01:00:00 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (US) • 03/03/2026 03:02:00 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (Canada) • 03/03/2026 03:02:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/03/2026 12:59:59 PM
- Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell • GlobeNewswire Inc. • 02/25/2026 04:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:45:34 PM
- Longeveron® Appoints Stephen H. Willard as Chief Executive Officer • GlobeNewswire Inc. • 02/13/2026 09:30:00 PM
